Access options
Subscribe to Journal
Get full journal access for 1 year
$259.00
only $21.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Smalley, E. First AAV gene therapy poised for landmark approval. Nat Biotechnol 35, 998–999 (2017). https://doi.org/10.1038/nbt1117-998
Published:
Issue Date:
Further reading
-
Targeted tPA overexpression in denervated spinal motor neurons promotes stroke recovery in mice
Journal of Cerebral Blood Flow & Metabolism (2021)
-
Expression and evaluation of porcine circovirus type 2 capsid protein mediated by recombinant adeno-associated virus 8
Journal of Veterinary Science (2021)
-
Positron emission tomography imaging of novel AAV capsids maps rapid brain accumulation
Nature Communications (2020)
-
Modifiers of Adeno-Associated Virus-Mediated Gene Expression in Implication for Serotype-Universal Neutralizing Antibody Assay
Human Gene Therapy (2020)
-
A rAAV2/6 Mutant with Enhanced Targeting for Mouse Retinal Müller Cells
Current Eye Research (2020)